"compound 25"-2

RORγt allosteric inhibitor

Orally bioavailable in higher species

from HTS and ligand-based design

ACS Med. Chem. Lett. 11, 114-119

Merck, Boston, MA

RORγt inhibitor from Merck (Merck ROR-gamma-t oral in vivo allosteric inhibitor)


 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.